Pathogenetic mechanisms in radiation fibrosis

Area of Science:

• Fibrosis research
• Extracellular matrix remodeling
• Cellular biology

Background:

• Fibrosis involves abnormal extracellular matrix remodeling due to deregulated regenerative responses.
• Pathological fibrosis shares common deregulated processes with fibrotic diseases affecting multiple organs.
• Transforming growth factor beta 1 (TGFβ1) is a key secreted factor driving fibrosis by activating myofibroblasts.

Purpose of the Study:

• To review the role of inflammation, myofibroblast origins and activation, and downstream pathways in common fibrotic states.
• To examine processes like oxidative stress, hypoxia, and microvascular damage in fibrotic diseases.
• To explore the relevance of early events, such as inflammatory responses, to fibrosis, particularly in the context of radiotherapy.

Main Methods:

• Review of existing literature on fibrosis mechanisms.
• Analysis of the role of specific factors like TGFβ1 and connective tissue growth factor.
• Consideration of contributing factors including oxidative stress, hypoxia, and microvascular damage.

Main Results:

• TGFβ1 initiates fibrosis by converting cells to myofibroblasts.
• Myofibroblast activation can perpetuate collagen production independently of TGFβ1 via connective tissue growth factor.
• Early inflammatory events' relevance to fibrosis remains an area of uncertainty.

Conclusions:

• Fibrosis involves complex cellular and molecular pathways, with TGFβ1 and myofibroblasts playing central roles.
• Further research, especially utilizing human tissue samples and interdisciplinary collaboration, is crucial for therapeutic advances.
• Understanding shared fibrotic processes across organs and in response to stimuli like radiotherapy offers significant therapeutic promise.